Research
Search entire Research Database
HomePublications

Immunomodulatory effects of 1,25(OH)(2)D-3 in normal and transformed human lung epithelium

Research output: Contribution to journal › Article

Authors

Organisational units

Details

Original languageEnglish
Pages (from-to)25
Number of pages1
JournalAnticancer Research
Volume31
Issue number4
Publication statusPublished - 2011
Peer-reviewedYes

View graph of relations

ID: 683784

Related by author

  1. Ferracyclic carbonyl complexes as anti-inflammatory agents

    Research output: Contribution to journal › Article

  2. Identification of selective protein-protein interaction inhibitors using efficient in silico peptide-directed ligand design

    Research output: Contribution to journal › Article

  3. Cyclometallated Au(III) dithiocarbamate complexes: synthesis, anticancer evaluation and mechanistic studies

    Research output: Contribution to journal › Article

  4. Acridine-decorated cyclometallated gold(III) complexes: synthesis and anti-tumour investigations

    Research output: Contribution to journal › Article

  5. Perfluoroarene-based peptide macrocycles that inhibit the Nrf2/Keap1 interaction

    Research output: Contribution to journal › Article

Related by journal

  1. Vitamin D: Potential in the prevention and treatment of lung cancer

    Research output: Contribution to journal › Article

  2. Immunomodulatory effects of 1, 25 (OH)2 D-3 in normal and transformed human lung epithelium

    Research output: Contribution to journal › Abstract

  3. ABSTRACTS OF THE 4TH INTERNATIONAL SYMPOSIUM ON VITAMIN D AND ANALOGS IN CANCER PREVENTION AND THERAPY

    Research output: Contribution to journal › Article

  4. Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines

    Research output: Contribution to journal › Article

© UEA. All rights reserved. University of East Anglia, Norwich Research Park, Norwich, Norfolk, NR4 7TJ, UK. Telephone: +44 (0) 1603 456161 Accessibility Legal Statements .